7 vs 14 Days of Antibiotics for Bacteremia, Factor XI Inhibition for Atrial Fibrillation, ACEi or ARB Before Elective Surgery, GLP-1 Agonist for HFpEF and Obesity
Last Week in Medicine
00:00
Factor XI and New Anticoagulants
This chapter delves into the critical role of factor XI in the clotting cascade and its implications for anticoagulation therapy. It discusses the efficacy of new medications like abilacimab and asindexion in preventing thromboembolic events while minimizing bleeding risks. The conversation also highlights recent clinical trials and their findings, suggesting cautious optimism for future treatments in this field.
Play episode from 26:11
Transcript
